Langer, Robert S.,Weight, Alisha K.,Larson, Alyssa M.,Klibanov, Alexander M.,Love, Kevin,Crane, Alan
申请号：
AU2020202408
公开号：
AU2020202408A1
申请日:
2020.04.06
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
#$%^&*AU2020202408A120200507.pdf#####ABSTRACT Concentrated, low-viscosity, low-volume liquid pharmaceutical formulations of proteins have been developed. Such formulations can be rapidly and conveniently administered by subcutaneous or intramuscular injection, rather than by lengthy intravenous infusion. These formulations include lowmolecular-weight and/or high-molecular-weight proteins, such as mAbs, and viscosity-reducing ionic liquids.
